CMPX - CIK 0001738021
Compass Therapeutics, Inc. (CMPX) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | -100.0% |
| FY 2024 | $850.00K | - |
| FY 2023 | $0.00 | - |
Compass Therapeutics, Inc. (CMPX) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.